A Randomized, Double-Blind, Placebo-Controlled, Study of Efficacy of DOLASETRON in Patients With Fibromyalgia.
Phase of Trial: Phase III
Latest Information Update: 01 May 2011
At a glance
- Drugs Dolasetron (Primary)
- Indications Fibromyalgia
- Focus Therapeutic Use
- 16 Oct 2009 Results presented at ACR 2009 (73rd Annual Scientific Meeting of the American College of Rheumatology and the 44th Annual Meeting of the Association of Rheumatology Health Professionals).
- 14 Jan 2009 New trial record.